BioCentury
ARTICLE | Clinical News

Non-ozone depleting aerosol formulations regulatory update

November 13, 2000 8:00 AM UTC

KOSP’s Aeropharm Technology Inc. subsidiary (Edison, N.J.) received U.S. Patents Nos. 6,129,905 and 6,136,294 covering aerosol formulations of pharmaceuticals for metered dose inhalers that do not use...